The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
The case highlights the need for clear and consistent guidance on driving when prescribed medical cannabis.
It is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
FOD is thought to affect an estimated 41% of women, but experts say it has been historically under-treated.
A new study suggests a combination approach may provide the benefits of THC treatment with fewer negative side effects.
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
A balanced CBD and THC cannabis flower was found to be more effective for treating acute migraine symptoms than a placebo.
Researchers say the new thresholds - modelled on alcohol units - could help people avoid potentially harmful consumption.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
